Product R&D
|
Scaffold selection |
Screening away from off-target acutely toxic compounds; often performed on compounds representing structural scaffolds of potential interest for new product development |
Candidate selection |
Choosing from among several molecules within one or more structurally active series with a goal of increasing the probability of technical success of a project by avoiding those having a greater safety liability (i.e., optimizing investment of resources) |
Study design support |
Selecting dose ranges, salt forms, and additional endpoints to optimize the design of in vivo and in vitro studies (e.g., in silico results can help identify potential target organs or mechanisms of toxicity, which can then be included as endpoints for investigation) |
Metabolite analysis |
Identifying probable test article metabolites and inform on their potential toxicity (e.g., through a bioactivation mechanism) |
Issue resolution |
Informing on potential mechanism(s) that could be associated with an observed toxicity; useful for forming hypotheses for testing. Confirmed mechanisms can be screened against to find more suitable candidates |
Scaffold hopping |
Identifying alternative structural series which continue to possess desirable properties without the continued presence or degree of undesirable off-target properties |
Weight of evidence |
Providing a basis for decisions when little or no data are available that used direct testing methods. Results are also useful for determining whether additional testing is needed |
Manufacturing and Process Chemistry
|
Green chemistry support |
Selecting occupationally or environmentally safer starting materials and additives |
Occupational Health and Safety
|
Worker safety |
Identifying compounds likely to pose a hazard to workers, e.g., through handling or accidental exposure |
Process control and containment |
Informing on the potential need for additional handling precautions |
Exposure limits |
Assisting in establishing safe exposure thresholds and limits |
Safety Data Sheet support |
Identifying the appropriate GHS classification when in vivo and in vitro test data are limited or do not exist |
Product Safety and Registration
|
Safety data for registration/approval |
Supporting product safety assessment (e.g., by providing the likelihood of involvement of a specific mechanism relating to a study finding) |
Product quality and specifications |
Supporting setting of limits for contaminants (e.g.,residuals, leachables and extractables, material interaction and degradation products) |
Classification and Labeling |
Informing labeling for intended use(s) |
Public Health and Safety / Environmental
|
Classification for product transport |
Identifying the appropriate GHS classification, when in vivo and in vitro test data are limited or do not exist, and assignment of the proper packing group. |
Environmental discharge limits / disposal |
Assisting in establishing limits and specifications for restricting environmental pollutants |
Accidental release situations |
Informing assessments of risk and strategies for mitigation or countermeasures |
Emergency Response
|
Intended or unintended acute exposure |
Informing assessments of risk and strategies for mitigation or countermeasures |
Military
|
Protection of military personnel |
Identifying hazards and informing assessments of risk and strategies for mitigation or countermeasures (i.e.,tactical preparedness) |